ERBB2 and neoplasm: A successful PET pre-imaging of antibody accumulation in tumor, followed by effective immunotherapy, was reported by Xu et al. [98], PET-visualization of HER-2 positive NIH3T6.7 tumor with 64Cu-labeled trastuzumab antibody was reported by Lee et al. [99].